|
Market Closed -
Nasdaq
02:30:00 14/11/2026 am IST
|
5-day change | 1st Jan Change | ||
| 28.83 USD | +1.05% |
|
-3.48% | +6.15% |
| 06/11 | Celldex Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026 | CI |
| 23/09 | Top Midday Decliners | MT |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| CLDX | Delayed | |
| CLDX | Real-time | ||
| TCE2 | Delayed | ||
| TCE2 | Real-time | ||
| TCE2 | Delayed | ||
| TCE1 | End-of-day quote | ||
| TCE2 | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bearish | Neutral |
| Resistance | 32.59 | 36.9 | 41.95 |
| Spread/Res. | -11.54% | -21.87% | -31.28% |
| Spread/Supp. | +4.72% | +4.72% | +25.35% |
| Support | 27.53 | 27.53 | 23 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- CLDX Stock
- Charts Celldex Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
















